138 related articles for article (PubMed ID: 762037)
1. Neuroleptic malignant syndrome due to depot fluphenazine.
Grunhaus L; Sancovici S; Rimon R
J Clin Psychiatry; 1979 Feb; 40(2):99-100. PubMed ID: 762037
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
3. Therapy with injectable fluphenazines.
Ayd FJ
Curr Psychiatr Ther; 1976; 16():177-89. PubMed ID: 991628
[No Abstract] [Full Text] [Related]
4. Tardive dyskinesia in outpatients on depot phenothiazine.
Neehall J
West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
[TBL] [Abstract][Full Text] [Related]
5. Iatrogenic morbidity in patients taking depot fluphenazine.
Jose C; Mallya A; Mehta D; Evenson R; Holland R
Am J Psychiatry; 1979 Jul; 136(7):976-7. PubMed ID: 453363
[No Abstract] [Full Text] [Related]
6. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
Ben Hadj Ali B; Dogui M; Ben Ammou S; Lôo H
Encephale; 1995; 21(3):209-15. PubMed ID: 7649071
[TBL] [Abstract][Full Text] [Related]
7. [Long-action neuroleptic agents (delayed-action neuroleptics)].
Ginestet D; Péron-Magnan P
Rev Prat; 1972 Apr; 22(12):1941-53. PubMed ID: 4675045
[No Abstract] [Full Text] [Related]
8. Depot fluphenazine: risk/benefit ratio.
Glazer WM
J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
[TBL] [Abstract][Full Text] [Related]
9. [Results of the use of fluphenazine in a depot preparation].
Marcjan K; Pietruszewska I; Wolak E
Psychiatr Neurol Med Psychol Beih; 1975; 20-21():176-82. PubMed ID: 829619
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R
Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445
[No Abstract] [Full Text] [Related]
11. [Tardive dystonia--a case report on therapy and metaphylaxis].
Genz A
Psychiatr Neurol Med Psychol (Leipz); 1988 May; 40(5):264-8. PubMed ID: 2905065
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of psychoses with a long-acting neuroleptic agent (fluphenazine decanoate). Clinico-psychopathological study of 53 patients].
La Mura G; Specchio LM; Corfiati L; Porro V; Bertolino A
Acta Neurol (Napoli); 1974; 29(4):446-59. PubMed ID: 4615572
[No Abstract] [Full Text] [Related]
13. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
[TBL] [Abstract][Full Text] [Related]
14. Depot neuroleptics in the treatment of acute psychoses.
Guarneri M; Placidi GF; Cassano GB
Encephale; 1979; 5(2):189-93. PubMed ID: 477594
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
Smulevich AB; Minsker EI; Mazaeva NA; Volkova RP; Lukanina SK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):912-20. PubMed ID: 5050051
[No Abstract] [Full Text] [Related]
16. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia complicated by hyperthyroidism.
Munetz MR; Ginchereau EH; Toenniessen LM
Psychosomatics; 1987 Oct; 28(10):553-5. PubMed ID: 3432519
[No Abstract] [Full Text] [Related]
18. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
20. [Out-patient treatment of psychoses using depot-fluphenazin].
Schmidt P
Psychiatr Neurol Med Psychol (Leipz); 1975 Apr; 27(4):231-8. PubMed ID: 1197460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
